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CML as an In Vitro Model of Allograft Reactions:
E. Goulmy and C. Mawas
THE papers summarized below reflect theincreased interest in cellular events in
the pre- and postrenal transplantation period.
PRETRANSPLANT PARAMETERS
Suthanthiran (New York) described an
interesting approach to detect latent cellular
presensitization in the potential allograft
recipients. His results indicated that by chem-
ical modification of the cell surface with
NAGO or IO 4" treatment, peripheral blood
lymphocytes (PBLs) from potential allograft
recipients exhibited cytolytic capacity in
contrast to PBLs from normal individuals.
F. Thomas (Greenville, N.C.) reported the
studies of Hoffman on pretransplant mea-
surement of in vitro generation of specific
anti-donor cytotoxic Τ cells. This suggests the
possibility of dividing, pretransplant, the
patients into low and high responders. The
pretransplant CML activity seems to be
predictive of the posttransplant rejection
course.
The results of Kerman (Houston) showed
predicting factors for prolonged allograft
survival. Pretransplant nonspecific immuno-
competence of the recipient, such as low
active Τ cells, low in vitro spontaneous blasto-
genesis, anergy to microbial skin test anti-
gens, and low MLC, correlated with longer
allograft survival.
DONOR-SPECIFIC CML NONREACTIVITY
Goulmy (Leiden) reported on donor-
specific CML nonreactivity in 39 patients
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from a group of 65 unrelated donor-recipient
combinations studied. The results from the
Leiden group indicated a significant correla-
tion with a good graft function and with the
HLA-B locus antigen match between donor
and recipient. Furthermore, they investigated
whether the absence of CML reactivity of the
recipients' lymphocytes towards the specific
kidney donor splenocytes could be due to lack
of helper cells. After Stimulation of the recip-
ients' lymphocytes towards a pool of stimula-
tor cells, no cytolytic aclivity against the
donor cells could be observed. However, when
such pool-stimulated effector cells were tested
on each cell of the pool individually as a
target, an HLA-B-dependent pattern of cyto-
lytic nonreactivity was observed.
Charpentier (Viliejuif, France) reported on
specific allogeneic unresponsiveness between
donor and recipient pairs. He pointed out that
in the case of acute cellular rejection, the
number of cytotoxic Τ lymphocytes in the
graft are much higher than those found in the
peripheral blood.
CML NONREACTIVITY AND DONOR-SPECIFIC
SUPPRESSOR CELLS
Kovithavongs (Edmonton Canada) de-
scribed an in vitro System to detect the
presence of posttransplant suppressor cells in
kidney transplant recipients' lymphocytes.
The mitomycin-treated recipient cells showed
only a suppressive effect when added as third-
party cells to the donor-specific stimulator
cells.
Pfeffer (Oslo, Norway) confirmed donor-
specific decreased CML activity in family
transplants. As controls, the cells of healthy
HLA-identical siblings were used. He found a
strenger decrease in secondary CML com-
pared to primary CML. Furthermore some
data were shown on the specific suppression
of the cytolytic activity. Pfeffer reported that
his suppressor cell System worked only with
the use of fresh cells.
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CML POSTER SESSION REVIEW
J. Thomas (Greenville, N.C.) suggested
that by removing recipient-adherent cells
(e.g., macrophages or monocytes) from the
CML cultures on day zero of sensitizing, a
loss of the donor-specific CML nonreactivity
results. This experimental model suggests
that the CML suppressor cell activity could
be associated with an adherent cell popula-
tion.
Mitchinson (London, England) suggested
looking specifically for suppressor cells by
cloning through limiting dilution. Several
groups have focussed on the existence of
suppressor cells in renal allograft recipients.
Suppressive effects of the recipients' lympho-
cytes after renal transplantation have been
observed using various protocols. Since there
are so many technical variations within these
clinical studies, a standardization of the tech-
niques and assignment criteria is a primary
concern.
Finally, van der Vegt (Maastricht, The
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Netherlands) reported on the detectiorf of
organ-specific antigens in a canine kidney
graft model. They found that cytotoxic Τ
lymphocytes were able to recognize different
antigens present on kidney cell targets and
absent on PHA-stimulated lymphoblasts.
Studies from Buurman (Maastricht) dem-
onstrated the presence of circulating "precur-
sor" CTLs in the canine kidney graft model.
After adherence of the CTLs to a monolayer
of stimulator cells, the nonadherent fraction,
which was devoid of CTL, seemed to be
responsible for cytotoxic activity identical to
the nonseparated suspensions.
In conclusion, cellular techniques have a lot
to offer for the in vitro monitoring of kidney
transplant recipients. Although all the results
obtained in this area bring us closer to the in
vivo Situation, many questions are still unan-
swered. Better and more defined protocols are
required to obtain a true in vitro correlate of
the homograft reaction.
